| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 15,900 | $30 | $540.6K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 29,150 | $10 | $291.5K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 35,800 | $1 | $143.2K |
| J0897 | Injection, denosumab, 1 mg | 6,420 | $20 | $115.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,230 | $90 | $112K |
| J3262 | Injection, tocilizumab, 1 mg | 21,080 | $10 | $105.4K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 8,190 | $10 | $65.5K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 1,690 | $30 | $43.9K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 390 | $50 | $18.9K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 140 | $100 | $13.8K |